Without FDA approval it means NOTHING, zero, zilch, nada.
Hence, the company announcing that the FDA process has been halted the market is pricing predictably.
With progress also being halted on IMM-529 it is clear that the company has all of its eggs in one basket. Unfortunately now that basket has been placed on some shelf in a back room, the lights have been turned out and it gathering dust.
WRAIR year in review 2019, page-2
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.006(5.71%) |
Mkt cap ! $22.57M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.9¢ | $32.90K | 328.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 27022 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
| IMC (ASX) Chart |